Trial · NCT03186209
Adverse events162
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 162
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dizziness | Nervous system disorders | Benralizumab 30 mg | 11 | 348 | 11 |
| other | Dizziness | Nervous system disorders | Placebo | 8 | 347 | 14 |
| other | Rhinitis allergic | Respiratory, thoracic and mediastinal disorders | Benralizumab 30 mg | 22 | 348 | 41 |
| other | Rhinitis allergic | Respiratory, thoracic and mediastinal disorders | Placebo | 15 | 347 | 17 |
| other | Hypertension | Vascular disorders | Benralizumab 30 mg | 7 | 348 | 7 |
| other | Hypertension | Vascular disorders | Placebo | 13 | 347 | 14 |
| serious | Arteriosclerosis coronary artery | Cardiac disorders | Benralizumab 30 mg | 1 | 348 | 1 |
| serious | Arteriosclerosis coronary artery | Cardiac disorders | Placebo | 0 | 347 | 0 |
| serious | Reflux gastritis | Gastrointestinal disorders | Benralizumab 30 mg | 1 | 348 | 1 |
| serious | Reflux gastritis | Gastrointestinal disorders | Placebo | 0 | 347 | 0 |
| serious | Atrial fibrillation | Cardiac disorders | Benralizumab 30 mg | 0 | 348 | 0 |
| serious | Atrial fibrillation | Cardiac disorders | Placebo | 1 | 347 | 1 |
| serious | Cholecystitis | Hepatobiliary disorders | Benralizumab 30 mg | 0 | 348 | 0 |
| serious | Cholecystitis | Hepatobiliary disorders | Placebo | 1 | 347 | 1 |
| serious | Cholelithiasis | Hepatobiliary disorders | Benralizumab 30 mg | 1 | 348 | 1 |
| serious | Cholelithiasis | Hepatobiliary disorders | Placebo | 0 | 347 | 0 |
| serious | Hepatic mass | Hepatobiliary disorders | Benralizumab 30 mg | 1 | 348 | 1 |
| serious | Hepatic mass | Hepatobiliary disorders | Placebo | 1 | 347 | 1 |
| serious | Food allergy | Immune system disorders | Benralizumab 30 mg | 1 | 348 | 1 |
| serious | Food allergy | Immune system disorders | Placebo | 0 | 347 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03186209/events?page=2